AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

OTCMKTS:ABSCFAAC Technologies Stock Price, Forecast & News

$9.35
0.00 (0.00 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.35
Now: $9.35
$9.35
50-Day Range
$8.10
MA: $9.37
$11.00
52-Week Range
$4.19
Now: $9.35
$11.00
Volume6,325 shs
Average Volume13,347 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the Masitinib, a tyrosine kinase inhibitor that is in Phase III trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases. The company is also developing AB8939 for the treatment of acute myeloid leukemia. The company markets its Masitinib under the Masivet brand in Europe. AB Science S.A. was founded in 2001 and is headquartered in Paris, France.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.66 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ABSCF
CUSIPN/A
CIKN/A
Phone33 1 47 20 00 14

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees109
Next Earnings DateN/A
OptionableNot Optionable

Receive ABSCF News and Ratings via Email

Sign-up to receive the latest news and ratings for ABSCF and its competitors with MarketBeat's FREE daily newsletter.

AAC Technologies (OTCMKTS:ABSCF) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of AAC Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AAC Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AAC Technologies.

Has AAC Technologies been receiving favorable news coverage?

News headlines about ABSCF stock have been trending very negative on Tuesday, InfoTrie Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. AAC Technologies earned a daily sentiment score of -3.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutAAC Technologies.

Who are some of AAC Technologies' key competitors?

Who are AAC Technologies' key executives?

AAC Technologies' management team includes the following people:
  • Mr. Alain Moussy, Co-Founder, Chairman, Pres, CEO & Scientific Director
  • Mr. Denis Gicquel, Head of Pharmaceutical Devel.
  • Mr. Laurent Guy MBA, Chief Financial Officer
  • Mr. Christian FASSOTTE, Global Chief Medical Officer
  • Mr. Alexis BERNARD, Head of Veterinary Sales

What is AAC Technologies' stock symbol?

AAC Technologies trades on the OTCMKTS under the ticker symbol "ABSCF."

How do I buy shares of AAC Technologies?

Shares of ABSCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AAC Technologies' stock price today?

One share of ABSCF stock can currently be purchased for approximately $9.35.

What is AAC Technologies' official website?

The official website for AAC Technologies is www.ab-science.com.

How can I contact AAC Technologies?

The company can be reached via phone at 33 1 47 20 00 14.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.